We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$28.9B
AUM Growth
-$1.88B
Cap. Flow
-$3.11B
Cap. Flow %
-10.73%
Top 10 Hldgs %
36.76%
Holding
1,184
New
80
Increased
351
Reduced
700
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 48.55%
2 Financials 9.72%
3 Consumer Discretionary 5.52%
4 Healthcare 4.26%
5 Communication Services 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NLY icon
1026
Annaly Capital Management
NLY
$17.1B
$257K ﹤0.01%
11,478
+385
+3% +$8.38K
MBX
1027
MBX Biosciences
MBX
$3.14B
$256K ﹤0.01%
+8,113
New +$197K
EYPT icon
1028
EyePoint Inc
EYPT
$1.03B
$255K ﹤0.01%
+13,983
New +$198K
RS icon
1029
Reliance Steel & Aluminium
RS
$20.7B
$254K ﹤0.01%
879
-30
-3% -$8.43K
DFTX
1030
Definium Therapeutics
DFTX
$5.78B
$253K ﹤0.01%
18,885
+6,210
+49% +$76.8K
SUPN icon
1031
Supernus Pharmaceuticals
SUPN
$2.59B
$252K ﹤0.01%
5,065
+385
+8% +$18.7K
MARA icon
1032
Marathon Digital Holdings
MARA
$4.32B
$248K ﹤0.01%
27,660
+2,657
+11% +$39.2K
ITT icon
1033
ITT
ITT
$17.5B
$248K ﹤0.01%
1,428
+80
+6% +$14.3K
LQDA icon
1034
Liquidia Corp
LQDA
$7.48B
$247K ﹤0.01%
+7,154
New +$204K
ECHO
1035
EchoStar
ECHO
$24.4B
$246K ﹤0.01%
+2,262
New +$184K
EWTX icon
1036
Edgewise Therapeutics
EWTX
$4.13B
$244K ﹤0.01%
+9,849
New +$198K
AMRX icon
1037
Amneal Pharmaceuticals
AMRX
$5.85B
$241K ﹤0.01%
19,148
+3,705
+24% +$42.4K
PRGO icon
1038
Perrigo
PRGO
$1.4B
$241K ﹤0.01%
17,294
+5,141
+42% +$85.7K
PCRX icon
1039
Pacira BioSciences
PCRX
$1.04B
$240K ﹤0.01%
+9,285
New +$221K
LGND icon
1040
Ligand Pharmaceuticals
LGND
$5.76B
$240K ﹤0.01%
1,270
-33
-3% -$6.34K
CIFR icon
1041
Cipher Digital
CIFR
$9.13B
$240K ﹤0.01%
16,266
+4,648
+40% +$82K
HZO icon
1042
MarineMax
HZO
$759M
$238K ﹤0.01%
9,838
-377
-4% -$9.3K
APG icon
1043
APi Group
APG
$17.1B
$238K ﹤0.01%
6,221
-174
-3% -$6.43K
RBC icon
1044
RBC Bearings
RBC
$17.4B
$237K ﹤0.01%
529
-14
-3% -$5.93K
WPC icon
1045
W.P. Carey
WPC
$16.8B
$237K ﹤0.01%
3,683
-101
-3% -$6.73K
IMKTA icon
1046
Ingles Markets
IMKTA
$1.71B
$237K ﹤0.01%
3,457
-336
-9% -$24.4K
PFGC icon
1047
Performance Food Group
PFGC
$18B
$237K ﹤0.01%
2,635
-69
-3% -$6.66K
RAPP
1048
Rapport Therapeutics
RAPP
$1.96B
$237K ﹤0.01%
+7,801
New +$216K
INDV icon
1049
Indivior Pharmaceuticals
INDV
$4.73B
$237K ﹤0.01%
+6,596
New +$201K
DBX icon
1050
Dropbox
DBX
$7.6B
$236K ﹤0.01%
8,496
-1,986
-19% -$57.8K

Similar funds

Rafferty Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Rafferty Asset Management held 1,184 positions worth $28.9B, down 6.1% from $30.8B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Rafferty Asset Management withdrew a net $3.11B in Q4 2025, closing 51 positions and reducing 700 holdings. Its most notable exit was GlobalFoundries, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 45% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Rafferty Asset Management opened a new position in Ferrovial N.V. Ordinary Shares worth $11.9M.

  • Rafferty Asset Management's largest Q4 2025 buy was Ferrovial N.V. Ordinary Shares: 186,539 shares worth $11.9M.
  • Rafferty Asset Management added most to Meta Platforms (Facebook) in Q4 2025, an estimated $122M increase.
  • Rafferty Asset Management's biggest Q4 2025 reduction was Tesla, cutting an estimated $1.04B.
  • Rafferty Asset Management fully exited GlobalFoundries in Q4 2025, selling an estimated $13.3M.
  • Rafferty Asset Management's ten largest holdings make up 37% of its $28.9B portfolio in Q4 2025.
  • Rafferty Asset Management opened 80 new positions and closed 51 in Q4 2025.
  • Rafferty Asset Management's portfolio value fell 6.1% quarter-over-quarter to $28.9B.

Based on Rafferty Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.